WANDA SECURES FUNDING PACKAGE
As it scales platform across the US
We are delighted to announce that portfolio company Wanda Health, the intelligent platform for Remote Patient Monitoring (“RPM”) and Virtual Care, has successfully closed an investment round and made significant commercial progress in the United States. The funding package also includes a £250,000 loan.
Wanda’s platform reduces hospitalisations and readmissions by collecting real-time data from patients at home or in community settings, and alerting clinicians to high-risk individuals.
Further investment for growth
Wanda has completed a further close of £834k consisting of EIS investments, a debt facility and CLA conversions, bringing the total closing under this investment round of £1.9m. The investment round was led by EMV Capital Partners Ltd, and the funding will be used to accelerate growth in response to inbound commercial interest. This fundraise follows a period of strong and accelerating commercial performance and further progress towards FDA approval of Wanda’s platform.
The £250,000 loan facility is being implemented to provide growth financing while Wanda delivers on its rapidly scaling customer uptake.
Commercial Progress in the US Market
Earlier in the year, Wanda secured partnerships with the COPD Foundation and the American Heart Association, strengthening the company’s access to key clinical opinion leaders in core focus areas. Since then, the company has made progress in several market segments.
Successful entry in the Pharmacy Benefit Managers segment, accelerating revenues
Wanda has now also successfully entered the Pharmacy Benefit Manager (“PBM”) segment. PBMs play a critical role in the US healthcare market by managing prescription drug benefits for over 275 million Americans.[1]
In the first half of the year, Wanda closed a new contract with Sav-Rx, a leading US PBM serving a network of over 65,000 pharmacies across the US,[2] and which has the potential to achieve multi-million annual recurring revenue (ARR) for the company. Onboarding has already started.
Wanda is also developing opportunities with other PBMs.
Provider Business
Wanda’s Provider Business is performing well, with an additional four new provider sites undertaking Medicare RTM; RPM; and CMM programmes with the company across Sleep Apnoea, Pain Management and General Chronic Disease Management.
Assisted Living
Wanda has also onboarded a group of assisted living facilities across California, which is a new use case for its team. The combined total of anticipated patient ramp-up equates to $300,000, realised at the end of 2025. Again, this revenue is recurring.
Tom Smith, Chief Executive Officer of Wanda, said:
“With new funding in place and key partnerships progressing well, we are now scaling our impact across the US. With the additional capital, we are well positioned to capitalise on the growing opportunities in the rapidly expanding digital remote monitoring market and to move closer to our mission of delivering the best-in-class intelligent virtual care.”
“Once fully onboarded, our existing contracts are projected to provide over $3.5m ARR, at which point we will target a Series A investment round. At that time, we expect our business to have a significantly higher valuation.”
“We are incredibly grateful to EMV Capital for their continued belief in Wanda’s mission. As a long-standing partner, their trust, insight, and support have been instrumental in helping us reach our next stage of growth. Closing this round with their backing reinforces our shared vision of transforming how people engage with their health. We are excited for what lies ahead – and proud to have EMV Capital with us on the journey.”
Dr Ilian Iliev, Chairman of Wanda and CEO of EMV Capital plc commented:
“We are delighted to support Wanda as it continues to develop and build out its platform, customer base, market strategy, and leadership team. With growing demand and a clearly defined regulatory pathway, the company is continuing well on its growth journey. We look forward to seeing Wanda’s impact grow, as it scales its operations across the US, and beyond.”